MetaboNews Issue 18 - February 2013 |
CONTENTS:
|
|
Note: Our
subscriber list is managed using Mailman, the GNU Mailing List
Manager. To subscribe or unsubscribe, please visit https://mail.cs.ualberta.ca/mailman/listinfo/MetaboNews
Current and back issues of this newsletter can be viewed from the newsletter archive (http://www.metabonews.ca/archive.html).
|
1) Laboratory Spotlight
|
2) MetaboInterviews
|
|
President and
CEO, Chenomx Inc., Edmonton, Alberta, Canada |
|
Biography Neil Taylor is a graduate of
the University of Alberta in the field of Electrical
Engineering. Soon after graduation he became involved in
various aspects of control systems engineering including
the development of software applications for control
system design and monitoring. He founded Taylor Industrial
Software right at the time of the introduction of the
first personal computers in 1981. Taylor Industrial
Software became one of the first PC-based software
companies in the field and was included as part of GE
Fanuc in 1996. The group exists as a key part of GE and is
still located in Edmonton.
Neil embarked on a new career of investing and supporting new technology companies. He was a co-founder of Chenomx in 2000 and has led the company ever since. His experience in software development, company management and growth has helped Chenomx grow into the leader in the field that it is today. |
|
3) Biomarker Beacon
|
4) Metabolomics
Current Contents
|
5) MetaboNews |
30 Jan 2013 |
Metabolomics
Innovation Centre Update
Members and colleagues of The Metabolomics Innovation Centre (TMIC) attended the "9th Annual Bellairs Research Workshop: Personalized Treatment of Liver Disease with Advanced Technology" from January 18th - 25th, 2013. The workshop was held in Folkestone, St. James, Barbados by McGill University at the Bellairs Research Institute, the only teaching and research institute in the tropics, founded nearly 60 years ago and endowed in 1954 by the late Commander Carlyon W. Bellairs. TMIC Principal Investigators, Dr. Liang Li and Dr. Christoph Borchers, presented talks on "Isotope Labeling LC-MS for Comprehensive and Quantitative Metabolome Profiling" and "Protein concentration coverage from mg/ml to pg/ml: Pushing the MRM based quantitation of plasma proteins with a cocktail mix of +700 standard peptides" and shared some details on the benefits of TMIC's metabolomic research for disease prevention, early detection and treatment. Drs. Borchers and Li, along with TMIC lead Dr. David Wishart, Connie Sobsey, University of Victoria, and Tamara Lim, University of Alberta, also took the opportunity to discuss some of the details regarding the upcoming Genome Canada Science and Technology Innovation Centre renewal in March 2013. TMIC is very excited to develop robust and innovative technological developments in the upcoming years and hopes to engage the research community and industry. Please help us out by taking part in our TMIC Community Needs Survey so that we can continue to impact Canadians with beneficial scientific research for the ongoing advancement of Science and Public & Environmental Health. |
25 Jan 2013 |
Thermo Fisher
Scientific and National University of
Singapore Form Collaboration on Metabolomics
Study of Urban Water Systems Goal
Thermo Fisher Scientific Inc., the world leader in serving science, and National University of Singapore's (NUS) Environmental Research Institute (NERI), a leading global interdisciplinary institute for environmental sciences and engineering announced that they have formed a collaboration to study how metabolism in plants and bacteria affects water quality and the ecosystem in and around Singapore. In the study, researchers from NERI and the Singapore Centre on Environmental Life Sciences Engineering (SCELSE), an interdisciplinary Research Centre of Excellence (RCE), funded by National Research Foundation, Singapore Ministry of Education, NUS and Nanyang Technological University, will examine how metabolomes (all the metabolites present in an organism at a given time) relate to the functioning of microbes in the urban water cycle. The team will employ a wide range of analytical tools including state-of-the-art liquid chromatography/mass spectrometry (LC-MS) systems to identify and measure metabolites in samples. One of the goals is to better understand and enhance the self-purification capacity of urban waterways that use natural processes to reduce or remove nutrient and contaminant loads in surface water. Another goal is to understand the metabolic basis of wastewater purification in order to improve the processes involved. "Safe and sustainable quality water is fundamental to both human and ecosystem health. By understanding better how plants and microbes affect our water quality, we could look into developing improved tools or methods that could significantly increase our ability to identify health and environmental threats more prudently. We are delighted to be partnering with Thermo Fisher Scientific in working towards this endeavor and believe that this collaboration that marries nature and technology will lead us to new findings that would benefit the society," said Professor Ong Choon Nam, Director of NUS Environmental Research Institute. "NERI and Thermo Fisher Scientific share the vision of helping to make the world healthier, cleaner and safer, which is why we are so delighted to team up with this group of expert scientists in environmental sciences," said Bhaskar Narayanaan, Vice President and General Manager, Thermo Fisher Singapore. "This combination of research expertise with Thermo Scientific analytical technology creates tremendous synergy." Under this collaboration:
|
14 Jan 2013 |
Metabolomics key to identifying disease
pathway: Research reveals lactic acid's role
in lung disease
Expertise at Pacific Northwest National Laboratory (PNNL) contributed to the understanding of the role of cellular metabolism in the pathogenesis of a currently untreatable lung disease. This research, reported in the American Journal of Respiratory and Critical Care Medicine, highlights the importance of PNNL's nuclear magnetic resonance (NMR) metabolomics in the field of biomedicine. "This work was, in fact, stimulated by the findings from our metabolic profiling studies," said Dr. Jianzhi Hu, a PNNL NMR expert and physicist who, with NMR spectroscopist and biochemist Nancy Isern, provided the study's NMR metabolomics data. The work was led by University of Rochester researchers Drs. Patricia Sime (MD), R. Matthew Kottmann (MD), and Richard Phipps (PhD) and included researchers from Inova Fairfax Hospital Heart & Vascular Institute and George Mason University. Scientists increasingly recognize that dysregulated, or impaired, cellular metabolism impacts disease processes. However, they know little about the role of cellular metabolism as it relates to lung disease. Greater understanding of the dysregulated processes in human diseases will help in developing improved diagnostic and treatment strategies. The researchers investigated how the metabolite lactic acid contributes to pulmonary fibrosis, or scarring of the lung. They identified increased levels of lactic acid and increased expression of the enzyme responsible for the production of lactic acid, lactate dehydrogenase (LDH), in the lung tissues of patients with idiopathic—from an unknown cause—pulmonary fibrosis (IPF) compared to healthy controls. Lactic acid, which is typically produced via LDH during vigorous exercise or other anaerobic conditions such as hypoxia, was also elevated in scar-forming cells in the lung called myofibroblasts. The team further demonstrated that the concentrations of lactic acid present in the diseased lung tissue activated an important fibrosis-promoting molecule, transforming growth factor beta (TGF-b). Furthermore, TGF-b was shown to increase the expression of LDH, thereby potentially contributing to a pro-fibrotic feed-forward loop. More important, the team also demonstrated that inhibition of LDH significantly reduced the fibrosis-promoting effects of TGF-b, thus identifying LDH as a novel potential target for therapy for patients with IPF. These data support the role of lactic acid and LDH5 in the initiation and/or progression of pulmonary fibrosis. While the concept of lactic acid elevation in tissue with restricted blood flow is not new, the concept that the elevated lactic acid concentrations are playing a key physiologic role in a lung disease represents a broader understanding of lung physiology. This work also highlights the importance of combining metabolomics studies with translational and clinical research. This study provides an exciting first step for a novel, direct measurement of metabolites and their associated metabolic pathways that are dysregulated in human lung disease. Many more metabolites have been identified as being either increased or decreased in IPF compared to healthy controls. Interrogation of their associated metabolic pathways is ongoing. This investigation is expected to help identify additional novel treatment targets for patients with IPF. In addition, the researchers are expanding their analyses to include other lung diseases, such as chronic obstructive lung disease (COPD), sarcoidosis, and other idiopathic lung disorders. Paper: Kottman, R. 2012. Lactic Acid is Elevated in Idiopathic Pulmonary Fibrosis and Induces Myofibroblast Differentiation Via pH-Dependent Activation of Transforming Growth Factor-β. American Journal of Respiratory and Critical Care Medicine 186(8):740-751. [PMID: 22923663] Source: Medical Xpress |
6) Metabolomics Events
|
9-13 Feb 2013 |
MSACL 2013 - Mass
Spectrometry Applications to the Clinical
Laboratory For more information, visit https://www.msacl.org/ |
25 Feb-1 Mar 2013 |
EMBO Practical Course on
Metabolomics: Bioinformatics for Life
Scientists Is it right for me? This course is aimed at advanced PhD students and post-doctoral researchers who are planning to improve their ability or learn new techniques in metabolomics and applying optimal data analysis methods using various bioinformatics tools in their research. The aim of this course is to familiarize the participants with advanced data analysis and data fusion methodologies and provide hands-on training on the latest analytical approaches and abilities to visualized and map metabolic changes on the relevant pathways. What will I learn? Lectures will give insight into how biological knowledge can be generated from metabolomics experiments and illustrate different ways of analyzing such data using variety of open source and freely available tools. Practicals will consist of computer exercises that will enable the participants to apply statistical methods and different analytical and data processing software to the analysis of metabolomics data under the guidance of the lecturers and teaching assistants. Familiarity with the technology such as data acquisition with NMR and MS is required. Ideally also some experience with R/Bioconductor (basic understanding of the syntax and ability to manipulate R objects) and the Unix/Linux operating system. What will it cover? The course covers optimal study design for metabolomics experiments, various data analysis methods, usage of online databases and resource as well theoretical a practical approaches on data fusion. Other topics will include: visualization of metabolomics data on metabolic pathways, methods of identification of unknown compounds, differential expression, data quality and reproducibility assessment using statistical analysis and optimal experimental study design. For more information, visit http://www.ebi.ac.uk/training/course/embo-practical-course-metabolomics-bioinformatics-life-scientists. |
8-10 Apr 2013 |
2nd International
Conference and Exhibition on Metabolomics
& Systems Biology Metabolomics-2013 is a remarkable event which brings together a unique and International mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions making the conference a perfect platform to share experience, foster collaborations across industry and academia, and evaluate emerging technologies across the globe. 2nd International Conference and Exhibition on Metabolomics & Systems Biology will serve as a catalyst for the advances in the study of Metabolomics & Systems Biology by connecting scientists within and across disciplines at sessions and exhibition held at the venue, creates an environment conducive to information exchange, generation of new ideas, and acceleration of applications that benefit research in Metabolomics & Systems Biology. For more information, visit http://omicsgroup.com/conferences/metabolomics-systems-biology-2013/. |
14-19 Apr 2013 |
54th ENC Conference
Preliminary Program: http://www.enc-conference.org/ConferenceDetails/Program/tabid/63/Default.aspx For more information, visit http://www.enc-conference.org/. |
1-7 June 2013 |
GRC on Computational NMR
and Associated Seminar on Metabolomic NMR The meeting is the eighth GRC on Computational NMR and the first to include a dedicated Seminar for graduate students and postdocs. The focus of the GRS is to discuss new contributions in computational Nuclear Magnetic Resonance to the growing field of metabolomics and will feature a keynote talk by David Wishart, University of Alberta, and discussions led by experts in metabolomic NMR as a complement to oral presentations by graduate students and postdocs. For more information: http://www.grc.org/programs.aspx?year=2013&program=grs_bionmr For registration: http://www.grc.org/application.aspx?id=15572 We do hope that you will both consider attending and provide this information to your students and postdocs and encourage them join us in Vermont for what we anticipate will be an enjoyable and stimulating meeting. |
1-4 Jul 2013 |
9th Annual International
Meeting of the Metabolomics Society We expect this to be the 'must attend' meeting in 2013 for researchers from around the world, where the best speakers in the world and rising stars of the future will present their work in a mixture of plenary and parallel sessions. The Metabolomics Society came into being with the development of the Metabolomics as a discipline and as a result provides a focus for the most varied aspects of the subject ranging from microbes to man. As a result of this it brings together a diverse mixture of scientists from many disciplines, which produces very stimulating meetings. One of the main aims of the conference will be to create a unique platform for young scientists. Come and listen and talk to the top experts in the field. Find out about the latest exciting technologies that can advance your own research, but most of all come and enjoy Scotland's largest and most vibrant city and the beautiful countryside around it. We look forward to welcoming you to Glasgow in 2013! Dave Watson Chair, Local Organising Committee Metabolomics Glasgow 2013 For more information, visit http://www.metabolomics2013.org/. |
2-4 Jul 2013 |
3rd European Lipidomic
Meeting
For more information, visit http://mab.uochb.cas.cz/iochb/ELM2013/. |
4-5 Jul 2013 |
Informatics and Statistics
for Metabolomics (2013) Target Audience: This course is intended for graduate students, post-doctoral fellows, clinical fellows and investigators who are interested in learning about both bioinformatic and cheminformatic tools to analyze and interpret metabolomics data. Prerequisite: Your own laptop computer. Minimum requirements: 1024x768 screen resolution, 1.5GHz CPU, 1GB RAM, recent versions of Windows, Mac OS X or Linux (Most computers purchased in the past 3-4 years likely meet these requirements). If you do not access to a laptop, you may loan one from the CBW. Please contact course_info@bioinformatics.ca for more information. Pre-Readings: You are expected to have completed the following tutorials in R beforehand. The tutorial should be very accessible even if you have never used R before. Please complete the following: R Tutorial For more information, visit http://bioinformatics.ca/workshops/2013/informatics-and-statistics-metabolomics-2013. |
13-17 Aug 2013 |
Metabolic Signaling &
Disease: From Cell to Organism Organizers: Daniel Kelly, Sanford-Burnham Medical Research Institute Mitchell Lazar, University of Pennsylvania Susanne Mandrup, University of Southern Denmark We are pleased to announce the first Cold Spring Harbor meeting on Metabolic Signaling & Disease: From Cell to Organism which will begin on Tuesday evening, August 13 and end at noon on Saturday, August 17, 2013. Metabolic regulation is at the intersection of many scientific fields, ranging from basic biochemistry and molecular biology to physiology, to the study of disease pathogenesis. Currently, a major challenge for these diverse fields is to define commonalities and differences in metabolic pathways and their regulation, and determine the role of these processes for physiology and disease states. This meeting will fill an important gap by bringing together outstanding researchers focused on diverse pathways, cell types, or diseases with a common theme of understanding how metabolism is regulated in physiology and disease states. For more information, visit http://meetings.cshl.edu/meetings/2013/metab13.shtml. |
7) Metabolomics Jobs |
This is a resource for
advertising positions in metabolomics. If you have a job
you would like posted in this newsletter, please email
Ian Forsythe (metabolomics.innovation@gmail.com).
Job postings will be carried for a maximum of 4
issues (8 weeks) unless the position is filled prior to
that date.
Jobs
Offered
Job Title | Employer | Location | Posted | Closes | Source |
---|---|---|---|---|---|
Postdoctoral
fellow in metabolic profiling of breast cancer |
Norwegian University of Science and Technology | Trondheim, Norway | 4-Feb-2013 |
27-Feb-2013 |
Metabolomics
Society |
Postdoctoral
fellow in preclinical prostate cancer research |
Norwegian University of Science and Technology | Trondheim, Norway | 4-Feb-2013 |
27-Feb-2013 |
Metabolomics
Society |
PhD
research project: "MR biomarkers for prostate
cancer aggressiveness" |
Norwegian University of Science and Technology | Trondheim, Norway | 16-Jan-2013 |
6-Feb-2013 |
Norwegian University of Science and Technology |
PhD
research project: "Imaging and targeting
metabolic pathways for personalized breast cancer
treatment" |
Norwegian University of Science and Technology | Trondheim, Norway | 16-Jan-2013 |
6-Feb-2013 |
Norwegian University of Science and Technology |
PhD
research project: "Molecular profiling of breast
cancer for improved diagnostic and prognostic
assessment" |
Norwegian University of Science and Technology | Trondheim, Norway | 16-Jan-2013 |
6-Feb-2013 |
Norwegian University of Science and Technology |
Post-doctoral
Position in Chemical Ecology/Metabolomics |
University of Utah | Salt Lake City, Utah, USA |
4-Jan-2013 |
15-Feb-2013 |
Metabolomics
Society |
Postdoctoral
fellowship in metabolomics of cancer models |
UCSF | San
Francisco, CA,
USA |
4-Jan-2013 | Metabolomics
Society |
|
Head
of Metabolomics |
MRC National
Institute for Medical Research (NIMR) |
London,
UK |
18-Dec-2012 |
15-Feb-2013 |
MRC
National Institute for Medical Research |
Post-doctoral
Position in Lipidomics/Metabolomics |
University of Pennsylvania | Philadelphia, PA, USA |
14-Dec-2012 | Metabolomics
Society |
|
Post-doctoral
position in biostatistical methods |
University of Calgary | Calgary, Alberta, Canada |
14-Dec-2012 | Metabolomics
Society |
Ian
J. Forsythe, M.Sc.
MetaboNewsEditor Department of Computing Science
University of Alberta 221 Athabasca Hall Edmonton, AB, T6G 2E8, Canada Email: metabolomics.innovation@gmail.com Website: http://www.metabonews.ca LinkedIn: http://ca.linkedin.com/in/iforsythe Twitter: http://twitter.com/MetaboNews Google+: https://plus.google.com/118323357793551595134 Facebook: http://www.facebook.com/metabonews |
This newsletter is
produced by The Metabolomics Innovation Centre
(TMIC,
http://www.metabolomicscentre.ca/) for the benefit
of the worldwide metabolomics community.
A single source destination for fee-for-service metabolic profiling including comprehensive metabolite identification, quantification, and analysis
|